Emily Herrett

Nov 19, 2024 | nature.com | Ruth Costello |Emily Herrett |Amir Mehrkar |Laurie Tomlinson |Christopher T. Rentsch

AbstractBiological evidence suggests ursodeoxycholic acid (UDCA)—a common treatment of cholestatic liver disease—may prevent severe COVID-19 outcomes. We aimed to compare the hazard of COVID-19 hospitalisation or death between UDCA users versus non-users in a population with primary biliary cholangitis (PBC) or primary sclerosing cholangitis (PSC).

Aug 10, 2023 | mentalhealth.bmj.com | Eoin McElroy |Emily Herrett |Kishan Patel |Dominik M. Piehlmaier

DiscussionOur study aimed to describe the disparity across a range of mental health outcomes between those who live alone versus with others, and whether the pandemic impacted on this disparity. Using data from longitudinal studies and EHRs, we found consistent evidence of poorer mental health in people who lived alone prior to the onset of the COVID-19 pandemic. Results from the longitudinal studies showed that the gap for psychological distress persisted through the pandemic.

May 12, 2023 | dovepress.com | Jennifer Davidson |Amitava Banerjee |Helen Strongman |Emily Herrett

Back to Journals » Clinical Epidemiology » Volume 15 Authors Davidson JA, Banerjee A, Strongman H, Herrett E, Smeeth L, Breuer J, Warren-Gash C Received 12 May 2023 Accepted for publication 14 July 2023 Published 1 September 2023 Volume 2023:15 Pages 911—921 DOI https://doi.org/10.2147/CLEP.S421062 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Professor Vera Ehrenstein Jennifer A Davidson,1 Amitava Banerjee,2 Helen...

Mar 7, 2023 | thelancet.com | Charlotte Warren-Gash |Jennifer Davidson |Helen Strongman |Emily Herrett

SummaryBackgroundWhile cardiovascular disease (CVD) is a risk factor for severe COVID-19, the association between predicted cardiovascular risk and severe COVID-19 among people without diagnosed CVD is unclear. MethodsWe carried out historical, population-based cohort studies among adults aged 40–84 years in England using linked data from the Clinical Practice Research Datalink.